At Meto, we emphasize that sustainable weight management requires more than just medication - it demands a holistic approach addressing nutrition, activity, psychology, and medical factors
Consult your healthcare provider for specific guidance
The qualifying diagnoses (HFpEF, uncontrolled hypertension, CKD, pre-diabetes, prior MI, prior stroke, PAD) are the conditions where GLP-1 trials have shown direct benefit or strong biological plausibility for benefit
Also, a generic version of Saxenda reached pharmacies in August 2025, and its 14% cheaper than Zepbound
Fat gain is possible if caloric intake remains calibrated to the elevated metabolic rate (3-7% above baseline) that GH/IGF-1 provided during the cycle